Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

NCT01991067 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Tick Borne Encephalitis

Interventions

BIOLOGICAL: TBE virus vaccine

Sponsor

Medical University of Vienna

Collaborators

[object Object]